Chiara Acquati1, Brad J Zebrack2, Anna C Faul3,4, Leanne Embry5, Christine Aguilar5, Rebecca Block6, Brandon Hayes-Lattin7, David R Freyer8,9, Steve Cole10. 1. Graduate College of Social Work, University of Houston, Houston, Texas. 2. School of Social Work, University of Michigan, Ann Arbor, Michigan. 3. Kent School of Social Work, University of Louisville, Louisville, Kentucky. 4. Department of Social Work, University of the Free State, Bloemfontein, South Africa. 5. The University of Texas Health Science Center at San Antonio, San Antonio, Texas. 6. MNR Analytics, Portland, Oregon. 7. Oregon Health and Science University, Portland, Oregon. 8. Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California. 9. Keck School of Medicine, University of Southern California, Los Angeles, California. 10. Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California.
Abstract
BACKGROUND: Cancer-related sexual dysfunction has been reported among adolescents and young adults (AYAs); however, its prevalence over time has not been examined. This longitudinal study investigated sexual dysfunction in AYAs over the course of 2 years after the initial diagnosis. METHODS: Young adult patients (18-39 years old) completed the Medical Outcomes Study Sexual Functioning Scale within the first 4 months of their diagnosis (n = 123) and again 6 (n = 107) and 24 months later (n = 95). An ordered multinomial response model analyzed changes in the probability of reporting sexual dysfunction over time and the independent effects of demographic, clinical, and psychosocial variables. RESULTS: More than half of the participants reported sexual functioning to be problematic at each assessment. The probability of reporting sexual dysfunction increased over time (P < .01) and was greater for cancer patients who were female (P < .001), older (P < .01), married or in a committed relationship (P < .001), treated with chemotherapy (P < .05), and reporting comorbid psychological distress (P < .001) and lower social support (P < .05). For women, being in a relationship increased the likelihood of reporting sexual problems over time; for men, the likelihood of reporting sexual problems increased regardless of their relationship status. CONCLUSIONS: A substantial proportion of young adults report ongoing problems with sexual functioning in the first 2 years after their cancer diagnosis. These findings justify the need to evaluate and monitor sexual functioning throughout a continuum of care. Cancer 2018;124:398-405.
BACKGROUND:Cancer-related sexual dysfunction has been reported among adolescents and young adults (AYAs); however, its prevalence over time has not been examined. This longitudinal study investigated sexual dysfunction in AYAs over the course of 2 years after the initial diagnosis. METHODS: Young adult patients (18-39 years old) completed the Medical Outcomes Study Sexual Functioning Scale within the first 4 months of their diagnosis (n = 123) and again 6 (n = 107) and 24 months later (n = 95). An ordered multinomial response model analyzed changes in the probability of reporting sexual dysfunction over time and the independent effects of demographic, clinical, and psychosocial variables. RESULTS: More than half of the participants reported sexual functioning to be problematic at each assessment. The probability of reporting sexual dysfunction increased over time (P < .01) and was greater for cancerpatients who were female (P < .001), older (P < .01), married or in a committed relationship (P < .001), treated with chemotherapy (P < .05), and reporting comorbid psychological distress (P < .001) and lower social support (P < .05). For women, being in a relationship increased the likelihood of reporting sexual problems over time; for men, the likelihood of reporting sexual problems increased regardless of their relationship status. CONCLUSIONS: A substantial proportion of young adults report ongoing problems with sexual functioning in the first 2 years after their cancer diagnosis. These findings justify the need to evaluate and monitor sexual functioning throughout a continuum of care. Cancer 2018;124:398-405.
Authors: Giselle K Perez; John M Salsman; Kaitlyn Fladeboe; Anne C Kirchhoff; Elyse R Park; Abby R Rosenberg Journal: Am Soc Clin Oncol Educ Book Date: 2020-03
Authors: Luciana Silveira Campos; Simone Pellin De Nardi; Leo Francisco Limberger; Jose Manoel Caldas Journal: Support Care Cancer Date: 2022-02-28 Impact factor: 3.603
Authors: Lauren V Ghazal; Steve Cole; John M Salsman; Lynne Wagner; Fenghai Duan; Ilana Gareen; Lauren Lux; Susan K Parsons; Christabel Cheung; David M Loeb; Pinki Prasad; Shira Dinner; Brad Zebrack Journal: JCO Precis Oncol Date: 2022-06
Authors: Ashley Wilder Smith; Theresa Keegan; Ann Hamilton; Charles Lynch; Xiao-Cheng Wu; Stephen M Schwartz; Ikuko Kato; Rosemary Cress; Linda Harlan Journal: Pediatr Blood Cancer Date: 2018-10-07 Impact factor: 3.167
Authors: Brooke Cherven; Amani Sampson; Sharon L Bober; Kristin Bingen; Natasha Frederick; David R Freyer; Gwendolyn P Quinn Journal: CA Cancer J Clin Date: 2020-12-07 Impact factor: 508.702
Authors: Jennifer Y Sheng; Cesar A Santa-Maria; Amanda L Blackford; David Lim; Ashley Carpenter; Karen L Smith; Gary I Cohen; Janelle Coughlin; Lawrence J Appel; Vered Stearns; Claire Snyder Journal: J Cancer Surviv Date: 2021-05-20 Impact factor: 4.062
Authors: Natasha N Frederick; Kristin Bingen; Sharon L Bober; Brooke Cherven; Xinxin Xu; Gwendolyn P Quinn; Lingyun Ji; David R Freyer Journal: Cancer Med Date: 2021-06-15 Impact factor: 4.452